Systemic anti-inflammatory treatments for PsO and PsA including methotrexate and biologics provided cardioprotective eff
Tweet Content
Systemic anti-inflammatory treatments for PsO and PsA including methotrexate and biologics provided cardioprotective effects
Potential cardiovascular benefits of IL-17i and IL-12/23i compared to TNFi
@RheumNow #ACR23 Abs#0498 https://t.co/Np7PSNvFd6
Show on Archive Page
On
Display in Search Results
On
PDQ
Off